Copeptin, IGFBP-1, and Cardiovascular Prognosis in Patients With Type 2 Diabetes and Acute Myocardial Infarction: A report from the DIGAMI 2 trial

OBJECTIVE: To determine whether C-terminal provasopressin (copeptin) explains the prognostic importance of insulin growth factor binding protein-1 (IGFBP-1) in patients with myocardial infarction and type 2 diabetes. RESEARCH DESIGN AND METHODS: Copeptin and IGFBP-1 were analyzed in 393 patients par...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellbin, Linda G., Rydén, Lars, Brismar, Kerstin, Morgenthaler, Nils G., Öhrvik, John, Catrina, Sergiu B.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890367/
https://www.ncbi.nlm.nih.gov/pubmed/20413521
http://dx.doi.org/10.2337/dc10-0088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890367/
https://www.ncbi.nlm.nih.gov/pubmed/20413521
http://dx.doi.org/10.2337/dc10-0088

Ejemplares similares